|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cance
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mocellin S, Verdi D, Pooley KA and Nitti
D: Genetic variation and gastric cancer risk: A field synopsis and
meta-analysis. Gut. 64:1209–1219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riquelme I, Saavedra K, Espinoza JA, Weber
H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC and Bizama C:
Molecular classification of gastric cancer: Towards a
pathway-driven targeted therapy. Oncotarget. 6:24750–24779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng
ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, et al:
microRNA-217 inhibits tumor progression and metastasis by
downregulating EZH2 and predicts favorable prognosis in gastric
cancer. Oncotarget. 6:10868–10879. 2015.PubMed/NCBI
|
|
9
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Dong G, Wang B, Gao W and Yang Q:
miR-543 promotes gastric cancer cell proliferation by targeting
SIRT1. Biochem Biophys Res Commun. 469:15–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang
F, Wu Y, Qi L, Fan Y, Chen Y, et al: Diagnostic value of a plasma
microRNA signature in gastric cancer: A microRNA expression
analysis. Sci Rep. 5:112512015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ibarrola-Villava M, Llorca-Cardeñosa MJ,
Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S,
Navarro S, Ribas G and Cervantes A: Deregulation of ARID1A, CDH1,
cMET and PIK3CA and target-related microRNA expression in gastric
cancer. Oncotarget. 6:26935–26945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge X, Liu X, Lin F, Li P, Liu K, Geng R,
Dai C, Lin Y, Tang W, Wu Z, et al: MicroRNA-421 regulated by HIF-1α
promotes metastasis, inhibits apoptosis, and induces cisplatin
resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Oncotarget. 7:24466–24482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du Y, Wang L, Wu H, Zhang Y, Wang K and Wu
D: MicroRNA-141 inhibits migration of gastric cancer by targeting
zinc finger E-box-binding homeobox 2. Mol Med Rep. 12:3416–3422.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu YL, Wang HF, Sun ZQ, Tang Y, Han XN, Yu
XB and Liu K: Up-regulated miR-155-5p promotes cell proliferation,
invasion and metastasis in colorectal carcinoma. Int J Clin Exp
Pathol. 8:6988–6994. 2015.PubMed/NCBI
|
|
16
|
Bhattacharya S, Chalk AM, Ng AJ, Martin
TJ, Zannettino AC, Purton LE, Lu J, Baker EK and Walkley CR:
Increased miR-155-5p and reduced miR-148a-3p contribute to the
suppression of osteosarcoma cell death. Oncogene. 35:5282–5294.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu M, Wang M, Yang F, Tian Y, Cai J, Yang
H, Fu H, Mao F, Zhu W, Qian H and Xu W: miR-155-5p inhibition
promotes the transition of bone marrow mesenchymal stem cells to
gastric cancer tissue derived MSC-like cells via NF-κB p65
activation. Oncotarget. 7:16567–16580. 2016.PubMed/NCBI
|
|
19
|
Zhu Y, Zhang C, Gu C, Li Q and Wu N:
Function of deubiquitinating enzyme USP14 as oncogene in different
types of cancer. Cell Physiol Biochem. 38:993–1002. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Price PM, Yu F, Kaldis P, Aleem E, Nowak
G, Safirstein RL and Megyesi J: Dependence of cisplatin-induced
cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am
Soc Nephrol. 17:2434–2442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li D, Liu X, Lin L, Hou J, Li N, Wang C,
Wang P, Zhang Q, Zhang P, Zhou W, et al: MicroRNA-99a inhibits
hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song B, Zhang C, Li G, Jin G and Liu C:
MiR-940 inhibited pancreatic ductal adenocarcinoma growth by
targeting MyD88. Cell Physiol Biochem. 35:1167–1177. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Q and Yu Y: Upregulated CDK16
expression in serous epithelial ovarian cancer cells. Med Sci
Monit. 21:3409–3414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, Xu Y, Qiu W, Zhao D and Zhang Y:
Tissue miR-193b as a novel biomarker for patients with ovarian
cancer. Med Sci Monit. 21:3929–3934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan B, Liang Y, Wang D and Luo F: MiR-940
inhibits hepatocellular carcinoma growth and correlates with
prognosis of hepatocellular carcinoma patients. Cancer Sci.
106:819–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
John B, Sander C and Marks DS: Prediction
of human microRNA targets. Methods Mol Biol. 342:101–113.
2006.PubMed/NCBI
|
|
31
|
Lee S, Paulson KG, Murchison EP, Afanasiev
OK, Alkan C, Leonard JH, Byrd DR, Hannon GJ and Nghiem P:
Identification and validation of a novel mature microRNA encoded by
the Merkel cell polyomavirus in human Merkel cell carcinomas. J
Clin Virol. 52:272–275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
An Y, Cai B, Chen J, Lv N, Yao J, Xue X,
Tu M, Tang D, Wei J, Jiang K, et al: MAP3K10 promotes the
proliferation and decreases the sensitivity of pancreatic cancer
cells to gemcitabine by upregulating Gli-1 and Gli-2. Cancer Lett.
329:228–235. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gallo KA and Johnson GL: Mixed-lineage
kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol.
3:663–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Z, Maroney AC, Dobrzanski P, Kukekov NV
and Greene LA: The MLK family mediates c-Jun N-terminal kinase
activation in neuronal apoptosis. Mol Cell Biol. 21:4713–4724.
2001. View Article : Google Scholar : PubMed/NCBI
|
